Invention Grant
- Patent Title: Modulators of retinoid-related orphan receptor gamma
-
Application No.: US13766076Application Date: 2013-02-13
-
Publication No.: US09657053B2Publication Date: 2017-05-23
- Inventor: Scott Thacher , Xiaolin Li , Robert Babine , Bruno Tse
- Applicant: ORPHAGEN PHARMACEUTICALS
- Applicant Address: US CA San Diego
- Assignee: ORPHAGEN PHARMACEUTICALS
- Current Assignee: ORPHAGEN PHARMACEUTICALS
- Current Assignee Address: US CA San Diego
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61K31/58
- IPC: A61K31/58 ; A01N41/06 ; A01N37/00 ; C07J9/00 ; C07C311/21 ; C07D401/14 ; C07J21/00 ; C07D249/12 ; C07D493/10

Abstract:
Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (RORγ) activity. This modulation has numerous effects, including inhibition of TH-17 cell function and/or TH-17 cell activity, and inhibition of re-stimulation of TH-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of RORγ results in stimulation of TH-17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines).
Public/Granted literature
- US20130150333A1 MODULATORS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA Public/Granted day:2013-06-13
Information query